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Abstract
Introduction Apoptosis of neutrophils (polymorphonuclear
neutrophils [PMNs]) may limit inflammatory injury in sepsis and
acute respiratory distress syndrome (ARDS), but the
relationship between the severity of sepsis and extent of PMN
apoptosis and the effect of superimposed ARDS is unknown.
The objective of this study was to correlate neutrophil apoptosis
with the severity of sepsis and sepsis-induced ARDS.
Methods A prospective cohort study was conducted in
intensive care units of three tertiary hospitals in Porto Alegre,
southern Brazil. Fifty-seven patients with sepsis (uncomplicated
sepsis, septic shock, and sepsis-induced ARDS) and 64
controls were enrolled. Venous peripheral blood was collected
from patients with sepsis within 24 hours of diagnosis. All
surgical groups, including controls, had their blood drawn 24
hours after surgery. Control patients on mechanical ventilation
had blood collected within 24 hours of initiation of mechanical
ventilation. Healthy controls were blood donors. Neutrophils
were isolated, and incubated ex vivo, and apoptosis was
determined by light microscopy on cytospun preparations. The
differences among groups were assessed by analysis of
variance with Tukeys.
Results In medical patients, the mean percentage of neutrophil
apoptosis (± standard error of the mean [SEM]) was lower in
sepsis-induced ARDS (28% ± 3.3%; n = 9) when compared
with uncomplicated sepsis (57% ± 3.2%; n = 8; p < 0.001),
mechanical ventilation without infection, sepsis, or ARDS (53%
± 3.0%; n = 11; p < 0.001) and healthy controls (69% ± 1.1%;
n = 33; p < 0.001) but did not differ from septic shock (38% ±
3.7%; n = 12; p = 0.13). In surgical patients with sepsis, the
percentage of neutrophil apoptosis was lower for all groups
when compared with surgical controls (52% ± 3.6%; n = 11; p
< 0.001).
Conclusion In medical patients with sepsis, neutrophil
apoptosis is inversely proportional to the severity of sepsis and
thus may be a marker of the severity of sepsis in this population.
ANOVA = analysis of variance; APACHE II = Acute Physiology and Chronic Health Disease Classification System II; ARDS = acute respiratory dis-
tress syndrome; BALF = bronchoalveolar lavage fluid; ERK = extracellular signal-regulated kinase; FITC = fluorescein isothiocyanate; GM-CSF = 
granulocyte macrophage-colony stimulating factor; ICU = intensive care unit; IL = interleukin; MODS = multiple organ dysfunction syndrome; MV = 
mechanical ventilation; p38 MAPK = p38 mitogen-activated protein kinase; PBS = phosphate-buffered saline; PI = propidium iodide; SEM = standard 
error of the mean; SIRS = systemic inflammatory response syndrome; SOFA = sequential organ failure assessment.Critical Care    Vol 10 No 6    Fialkow et al.
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Introduction
Sepsis is a leading cause of death in intensive care unit (ICU)
patients [1], with an estimated incidence of 700,000 cases
per year in the United States resulting in more than 200,000
deaths annually [2,3]. Acute respiratory distress syndrome
(ARDS) is a frequent complication of sepsis [4-6]. The mortal-
ity rate of ARDS remains high, ranging between 20% and
60% [4,7-13]. Leucocytes, including neutrophils and macro-
phages, are believed to contribute to inflammatory tissue injury
in sepsis and ARDS. It is hypothesised that unrestrained
release of leucocyte-derived cytotoxic products contributes to
injury of lungs and other organs [14-16]. A better understand-
ing of the pathophysiology of sepsis and ARDS is essential for
the treatment or prevention of these devastating conditions.
Apoptosis is involved in removal of senescent cells and is
thought to be essential for the non-injurious resolution of
inflammation [17-27]. The role of apoptosis in the pathophysi-
ology of sepsis and multiple organ dysfunction syndrome
(MODS) has been the focus of recent studies. There is evi-
dence of an association between apoptosis and outcomes of
patients with MODS [15,20,22,23,25,28]. Recent studies
suggest that neutrophil apoptosis is decreased in systemic
inflammatory response syndrome (SIRS) [28,29], sepsis [30-
37], and ARDS [12,14,16,26,38-40]. The increased life span
of neutrophils may be associated with increased tissue injury
in these syndromes [12,14-16,20,22,29]. Currently, informa-
tion on the relationship between neutrophil apoptosis and the
severity of sepsis and sepsis-induced ARDS is incomplete
[22,23,32-35,41]. Accordingly, the objective of the current
study was to determine whether neutrophil apoptosis corre-
lates with the severity of sepsis and sepsis-induced ARDS.
Materials and methods
Patient selection and study protocol
A prospective cohort study enrolled patients at three tertiary
teaching hospitals in Porto Alegre city, southern Brazil, from
January 2000 to December 2004. Patients were included in
the study if they met criteria for sepsis and ARDS.
Sepsis
Sepsis and its subsets were defined according to the Consen-
sus Conference of the American College of Chest Physicians
and the Society of Critical Care Medicine [1]. Sepsis, a sys-
temic inflammatory response secondary to infection, was
defined by two or more of the following criteria: (a) body tem-
perature greater than 38°C or less than 36°C, (b) heart rate
greater than 90 beats per minute, (c) respiratory rate greater
than 20 breaths per minute or a PaCO2 (arterial partial pres-
sure of carbon dioxide) less than 32 mm Hg, and (d) leuco-
cytes greater than 12,000 cells per cubic millimetre, less than
4,000 cells per cubic millimetre, or greater than 10% bands.
Septic shock was defined as sepsis-induced hypotension,
despite adequate fluid resuscitation, along with the presence
of hypoperfusion abnormalities or organ dysfunction. In our
study, the term 'uncomplicated sepsis' was used for patients
with sepsis according to the Consensus criteria instead of the
more frequently used, but ambiguous, term 'sepsis.'
ARDS
ARDS was defined according to criteria of the 1994 Ameri-
can-European Consensus Conference on ARDS [42]. These
included acute hypoxemia, ratio of PaO2 (arterial partial pres-
sure of oxygen) to FiO2 (fraction of inspired oxygen) of 200 mm
Hg or less, bilateral infiltrates on chest x-ray, pulmonary artery
wedge pressure less than or equal to 18 mm Hg, or no clinical
evidence of left atrial hypertension.
Control groups
1. Healthy controls were healthy blood donors (more than 18
years old) at the Hospital de Clínicas de Porto Alegre.
2. Surgical controls were patients submitted for elective sur-
gery who had no evidence of infection, sepsis, or ARDS. Stud-
ies suggest that surgery itself has an influence on neutrophil
apoptosis [43-46].
3. The mechanical ventilation (MV) group consisted of patients
submitted to MV but without evidence of infection, sepsis, or
ARDS. The objective was to verify whether the MV itself influ-
enced neutrophil apoptosis. All patients of this group were on
MV for a period of 24 hours.
Exclusion criteria
Exclusion criteria were congestive heart failure, ARDS sec-
ondary to factors other than sepsis (for example, pancreatitis,
burns, and multiple trauma), interstitial lung disease, use of
immunosuppressive drugs (for example, corticosteroids),
AIDS, malignancies, chronic inflammatory diseases (for exam-
ple, rheumatoid arthritis), and transfusion of blood or blood
products within the preceding 24 hours.
Ethical issues
The study was approved by the hospitals' ethics committees,
and informed consent was obtained from the patient or a sur-
rogate and from the healthy volunteers.
Sample and data collection
The venous blood sampling of medical patients was per-
formed within 24 hours of diagnosis of sepsis and its subsets,
ARDS, and for patients on MV. All surgical groups, including
controls, had their blood drawn 24 hours after surgery. For
healthy controls, a blood sample was obtained at the time of
blood donation. The investigators followed each patient
admitted to the ICU to identify patients who fulfilled the entry
criteria. For each patient, a data record was completed and
stored in a data bank.Available online http://ccforum.com/content/10/6/R155
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Study variables
Outcome variables
The primary outcome variable was mean percentage of neu-
trophil apoptosis.
Independent variables
Independent variables were age, gender, medical/surgical
patient status, Acute Physiology and Chronic Health Disease
Classification System II (APACHE II) score, total maximum
sequential organ failure assessment (SOFA) score, organ sys-
tem failure based on the SOFA score, and 28-day mortality
from the time of entry into the study. If the patient was dis-
charged from the hospital, mortality was assessed by tele-
phone or mail.
Study procedures
Neutrophil isolation
Human neutrophils (more than 98% pure) were isolated from
whole blood using dextran sedimentation and discontinuous
plasma-Percoll (Amersham Biosciences AB, now part of GE
Healthcare, Little Chalfont, Buckinghamshire, UK) gradients
as described previously [47]. The separation procedure
required two hours, and the cells were used immediately after
isolation for the experiments described. The functional integ-
rity and non-activated state of isolated neutrophils have been
validated in previous reports [47,48]. Neutrophil viability was
greater than 97% using Trypan blue exclusion.
Neutrophil apoptosis
After isolation, neutrophils were washed twice and resus-
pended at a density of 1 × 106 cells per millilitre in RPMI 1640
with 10% foetal bovine serum, L-glutamine (2 mM), penicillin
(100 mg/ml), and streptomycin (100 μg/ml) (Gibco, now part
of Invitrogen Corporation, Carlsbad, CA, USA). Cells were
then incubated at 37°C in a 5% CO2 atmosphere for 24 hours
in polypropylene tubes to prevent adherence. Cell viability
assessed by Trypan blue exclusion exceeded 97%. After 24
hours, neutrophils were sedimented by cytocentrifugation on a
glass microscope slide as described below.
Quantification of neutrophil apoptosis
Neutrophil apoptosis was assessed by light microscopy
(×200) analysis of cytospun cells stained with Wright's
Giemsa method and identification of nuclear changes (con-
densation of chromatin and simplification of nuclear structure)
characteristic of apoptosis [17,49,50]. Two blinded investiga-
tors assessed the percentage of neutrophil apoptosis on cyt-
ospun preparations by analysing 500 cells per slide each. The
analysis was performed on two different slides from the same
patient. Data were reported as the percentage of apoptotic
cells. The percentage was obtained by using the mean value
obtained by the two investigators.
To validate the light microscopic method of assessment of
neutrophil apoptosis, we used a second independent method
in healthy donors, annexin V binding with quantification by flow
cytometry [51]. In brief, neutrophils (1 × 106) were washed
with ice-cold phosphate-buffered saline (PBS) and then incu-
bated with fluorescein isothiocyanate (FITC)-conjugated
annexin V (R&D Systems, Inc., Minneapolis, MN, USA) in the
presence of propidium iodide (PI) for 30 minutes at 4°C. Cells
were washed, resuspended in PBS, and analysed by flow
cytometry (FACStar; Becton Dickinson, Mountain View, CA,
USA). Cells that were FITC-positive and PI-negative were con-
sidered to be apoptotic. The extent of neutrophil apoptosis
was compared with the percentage of neutrophil apoptosis
determined by nuclear morphology and light microscopy (lin-
ear regression slope 0.87 R2 = 0.968, n = 6). These results
confirm the validity of Wright's Giemsa staining to assess
apoptosis.
Sample size
The sample size was calculated using data from the study
patients because there was no information in the literature to
help sample size estimation. The study power for the study
comparisons was 90%.
Data quality control
A database coordinator was responsible for monitoring all
data collection and entry. All data were checked for any incon-
sistencies. A random sample of 20% of the records was
selected and compared with the original data-collection forms
to detect any data-entry errors.
Statistical analysis
A stratified analysis was performed considering the status of
medical or surgical patients. For each strata, the percentage
of neutrophil apoptosis measured in the different groups was
compared using one-way analysis of variance (ANOVA), con-
sidering that the study variables were normally distributed and
that the variances were equal. All comparisons with a p value
less than 0.05 were considered statistically significant. A post
hoc Tukey test was used. Continuous variables, other than the
percentage of neutrophil apoptosis, were also compared
using ANOVA and the post hoc Tukey tests. For continuous
variables comparing two groups, the Student t test was used.
Categorical variables were compared using the χ2 test. Corre-
lation analysis (Pearson) was performed between the main
outcome of neutrophil apoptosis and other continuous varia-
bles, including age and APACHE II and SOFA scores, strati-
fied for medical and surgical status. All analyses were
performed using the Statistical Package for Social Sciences,
version 12 (SPSS Inc., Chicago, IL, USA).
Results
A total of 57 patients and 64 controls were included in the
study (see Table 1 for population characteristics). A detailed
description of the diagnoses, sites of infection, microbiology,
and sources of materials for culture from all patients isCritical Care    Vol 10 No 6    Fialkow et al.
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included in Table 2 (medical patients) and Table 3 (surgical
patients).
The comparison of the percentage of neutrophil apoptosis
was significantly different among all groups (p < 0.001;
ANOVA). A stratified analysis was performed considering sur-
gical/medical status. The mean percentage of neutrophil
apoptosis (± standard error of the mean [SEM]) was signifi-
cantly lower in the surgical controls (52% ± 3.6%) when com-
pared with healthy controls (69% ± 1.1%; p = 0.001; Student
t test).
In medical patients, a significant difference was observed in
the age variable (Table 4). The control group was younger than
the MV group (p = 0.02; Tukey test). A Pearson correlation
test showed a weak and negative correlation (p  = 0.35)
between age and neutrophil apoptosis, suggesting that age
did not have a major effect on the percentage of neutrophil
apoptosis in this study (data not shown).
Neutrophil apoptosis differed significantly among the groups
of medical patients. Figure 1 shows images of neutrophil
apoptosis in Wright's Giemsa-stained slides obtained from a
healthy control (a) and from a patient with ARDS (b). The per-
centage of neutrophil apoptosis (± SEM) was lower in ARDS
(28% ± 3.3%; n = 9) compared with uncomplicated sepsis
(57% ± 3.2%; n = 8; p < 0.001), MV (53% ± 3.0%; n = 11;
p < 0.001), and with healthy controls (69% ± 1.1%; n = 33;
p < 0.001). However, it did not differ from septic shock (38%
± 3.7%; n = 12; p = 0.13) (Tukey test; Figure 2). In the septic
shock group, the mean percentage of neutrophil apoptosis
was significantly lower than in uncomplicated sepsis, MV, and
healthy controls (p < 0.001; Tukey test). The mean percentage
of neutrophil apoptosis was significantly lower in patients with
uncomplicated sepsis (p = 0.02; Tukey test) and in the MV
group (p < 0.001; Tukey test) compared with healthy controls.
There was no difference in the mean percentage of neutrophil
apoptosis between the uncomplicated sepsis and the MV
groups (p = 0.8; Tukey test). These observations suggest that
in medical patients, the severity of sepsis is inversely propor-
tional to the mean percentage of neutrophil apoptosis (Figure
2).
Variables such as 28-day mortality and APACHE II and SOFA
scores were also analysed in the medical groups (Table 4).
Twenty-eight-day mortality was higher in the ARDS and septic
shock groups when compared with the group with uncompli-
cated sepsis (Table 4). ARDS and septic shock groups had a
higher mean SOFA score when compared with the other
groups (p < 0.001; Tukey test) (Table 4). However, no statis-
tical difference was observed between the ARDS and septic
shock groups (p = 0.3; Tukey test).
Detailed data regarding number of organ dysfunctions/fail-
ures, according to SOFA score, are summarised in Table 4.
Many patients with uncomplicated sepsis developed organ
failure after blood sampling and during their hospitalisation in
the ICU.
In surgical patients, the mean percentage of neutrophil apop-
tosis in all groups (uncomplicated sepsis [p = 0.04], septic
shock [p = 0.04], ARDS [p < 0.002], and MV [p = 0.007]
groups [Tukey test]) was significantly lower than in controls
(Figure 3). No statistical difference was found among the
mean percentage of neutrophil apoptosis of uncomplicated
sepsis, septic shock, ARDS, and MV groups. Other variables
were also analysed in surgical groups (Table 5).
We attempted to perform a subgroup analysis based on the
different degrees of severity of sepsis in medical and surgical
patients to ascertain whether there was an association
between neutrophil apoptosis and mortality. This was not suc-
cessful, probably due to the small sample size studied. A mod-
erate and negative correlation between the mean SOFA score
and the percentage of neutrophil apoptosis in medical patients
was observed (R = -0.56; p < 0.001), indicating that the lower
the mean percentage of apoptosis, the higher the mean SOFA
score. However, in surgical patients, this correlation was weak
and not statistically significant.
Discussion
The primary observation of the current study is that the extent
of neutrophil apoptosis correlates inversely with the severity of
sepsis and sepsis-induced ARDS in medical patients. Neu-
trophils from medical patients with uncomplicated sepsis, sep-
tic shock, and ARDS displayed lower degrees of apoptosis as
compared with controls. Furthermore, we observed a progres-
sive decrease in neutrophil apoptosis as the severity of sepsis
increased. This is the first study to correlate the extent of apop-
Table 1
Characteristics of the study population according to group allocation
Variables Uncomplicated sepsis 
(n = 16)
Septic shock 
(n = 23)
Sepsis-induced ARDS 
(n = 18)
Mechanical ventilation 
(n = 20)
Controls 
(n = 44)
P valuea
Age (years, mean ± SEM) 57 ± 3.3 57 ± 4.5 46 ± 4.4 54 ± 3.5 43 ± 1.8 0.002
Male/Female (percentage) 62.5/37.5 52.2/47.8 50/50 55/45 50/50 0.93
Medical/Surgical (percentage) 50/50 52.2/47.8 50/50 55/45 75/25 -
aAnalysis of variance or χ2 test. ARDS, acute respiratory distress syndrome; SEM, standard error of the mean.Available online http://ccforum.com/content/10/6/R155
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Table 2
Detailed description of the medical patients
Patient Group
Uncomplicated sepsis (n = 8)
Diagnosis Site of infection Microorganism Material
1 Pneumonia/COPD Respiratory Not identified Sputum/Blood
2 Pneumonia/COPD Respiratory Staphylococcus aureus Blood
3 Pneumonia/Stroke Respiratory Not identified Sputum/Blood
4 Pneumonia/Guillain-Barre 
syndrome
Respiratory Enterobacter sp Sputum
5 Pneumonia/Subarachnoid 
hemorrhage
Respiratory Staphylococcus sp Blood
6 Pneumonia/DM/Pickwick 
syndrome
Respiratory Not identified Sputum/Blood
7 Pneumonia/Head trauma Respiratory Pseudomonas aeruginosa Sputum
8 Pneumonia/Intracerebral 
hemorrhage
Respiratory S. aureus Sputum
Septic shock (n = 12)
Diagnosis Site of infection Microorganism Material
1 Pneumonia/COPD Respiratory S. aureus Blood
2 Pneumonia Respiratory S. aureus Sputum
3 Pneumonia/COPD Respiratory S. aureus Blood
4 Pneumonia/COPD Respiratory P. aeruginosa/Haemophilus 
influenzae
Sputum
5 Pneumonia/UTI Respiratory/Urinary Not identified/Klebsiella 
pneumoniae
Sputum/Urine
6 Pneumonia/UTI/DM Respiratory/Urinary Not identified/Candida sp Sputum/Blood and urine
7 UTI/SBP/Cirrhosis Abdominal/Urinary S. aureus and Streptococcus 
viridans/Enterococcus 
faecium, S. viridans, and 
Escherichia coli
Ascites/Urine
8 Pneumonia Respiratory Not identified Sputum/Blood
9 Pneumonia/COPD Respiratory Not identified Sputum/Blood
10 Meningitis CNS Neisseria meningitis Liquor/Blood
11 UTI/Lyell syndrome Urinary/Skin Enterococcus sp/
Acinetobacter sp
Urine/Skin secretion
12 Pneumonia Respiratory S. aureus Blood
Sepsis-induced ARDS (n = 9)
Diagnosis Site of infection Microorganism Material
1 Pneumonia/Leptospirosis Respiratory Enterobacter sp Sputum
2 Pneumonia/Suicide attempt 
(glicosate ingestion)
Respiratory P. aeruginosa Sputum
3 Pneumonia/UTI/Diarrhea Respiratory, Urinary, and 
Intestinal
Not identified/K. pneumoniae/
E. coli OH157
Sputum/Urine/FecesCritical Care    Vol 10 No 6    Fialkow et al.
Page 6 of 14
(page number not for citation purposes)
4 Pneumonia/UTI/DM Respiratory/Urinary Streptococcus agalactiae, S. 
aureus/Staphylococcus sp, E. 
coli
Blood/Urine
5 Pneumonia Respiratory Haemophilus sp Sputum
6 Septic arthritis Joint S. aureus Sinovial liquid
7 Pneumonia Respiratory Not identified Sputum/Blood
8 Pneumonia Respiratory E. coli, Moraxella sp Sputum
9 Pneumonia/COPD Respiratory Not identified Sputum/Blood
Mechanical ventilation (n = 11)
Diagnosis
1 Anaphylaxis (anaesthesia)
2 Head trauma
3 Spinal cord trauma
4 Subarachnoid hemorrhage
5 Subarachnoid hemorrhage
6 Intracerebral hemorrhage
7 Anaphylaxis (anaesthesia)
8 Guillain-Barre syndrome
9 Intracerebral hemorrhage
10 Anaphylaxis (anaesthesia)
11 Epilepsy
ARDS, acute respiratory distress syndrome; CNS, central nervous system; COPD, chronic obstructive respiratory disease; DM, diabetes mellitus; 
SBP, spontaneous bacterial peritonitis; UTI, urinary tract infection.
Table 3
Detailed description of the surgical patients
Patient Group
Uncomplicated sepsis (n = 8)
Diagnosis Site of infection Microorganism Material Surgery
1 Pneumonia/Intracerebral 
haemorrhage
Respiratory Pseudomonas aeruginosa Sputum Craniotomy
2 Pneumonia/COPD Respiratory P. aeruginosa Sputum Aortic-femoral bypass
3 Pneumonia/Perforated ulcer Abdominal Candida albicans Ascites Laparatomy
4 Cholangitis/UTI Abdominal/Urinary Enterococcus sp/Escherichia coli Blood/Urine Exploratory laparotomy
5 Pneumonia/Peritonitis/
Colonic perforation due to 
colonoscopy
Respiratory/Abdominal Enterobacter sp/Not identified Sputum/Blood Exploratory laparotomy
6 Cholecystitis Abdominal Enterococcus sp Blood Cholecystectomy
7 Pneumonia/Intracerebral 
haemorrhage
Respiratory Enterobacter sp, Haemophilus sp, 
and Staphylococcus aureus
Sputum Craniotomy
8 Pneumonia/Stroke/UTI/
Celulitis
Respiratory/Urinary/Skin Not identified/Enterobacter sp/S. 
aureus
Sputum/Urine/Skin 
secretion
Abdominal aortic 
aneurysm repair
Table 2 (Continued)
Detailed description of the medical patientsAvailable online http://ccforum.com/content/10/6/R155
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Septic shock (n = 11)
Diagnosis Site of infection Microorganism Material Surgery
1 Pneumonia Respiratory/Catheter P. aeruginosa/S. aureus Sputum/Catheter Carotid aneurysm repair
2 Diverticulitis/UTI Abdominal/Urinary Not identified/Candida sp Blood/Urine Small bowel resection 
with anastomosis
3 Perforated peptic ulcer/
Cirrhosis/Alcohol abuse
Abdominal S. aureus Blood/Ascites Laparatomy
4 Septic arthritis (Hip) Joint Streptococcus agalactiae Joint fluid Surgical drainage
5 Pneumonia/Head trauma 
(subdural haematoma)
Respiratory Not identified Sputum/Blood Craniotomy
6 Pyelonephritis/Nephrolitiasis/
Neurogenic bladder
Urinary Staphylococcus sp/P. aeruginosa Blood/Urine Nephrectomy and 
abscess drainage
7 Perforated peptic ulcer Abdominal S. aureus, Streptococcus viridans, 
and Enterobacter sp
Ascites Exploratory laparotomy
8 Pneumonia/Endocarditis/
Intracerebral haemorrhage
Respiratory/Heart Pseudomonas sp/Not identified Sputum/Blood Craniotomy
9 Pneumonia/COPD/UTI 
Oesophageal laceration
Respiratory/Urinary S. aureus and Acinetobacter sp/E. 
coli
Sputum/Urine Oesophageal laceration 
repair
10 Cholangitis Abdominal E. coli Blood Exploratory laparotomy
11 Peritonitis/Perforated peptic 
ulcer
Abdominal Enterococcus sp, Candida sp, and 
S. aureus
Ascites Laparotomy
Sepsis-induced ARDS (n = 9)
Diagnosis Site of infection Microorganism Material Surgery
1 Cholangitis Abdominal Klebsiella pneumoniae Ascites Hepatic artery aneurysm 
ligation
2 Diverticulitis Abdominal E. coli Blood Small bowel resection 
with anastomosis
3 Pneumonia Respiratory P. aeruginosa Sputum Pleurostomy closure
4 Pneumonia Respiratory Staphylococcus coag neg Blood C-section
5 Septic arthritis Hip joint Staphylococcus haemolyticus Blood Hip drainage
6 UTI/Intestinal fistula Urinary Candida sp and Enterococcus sp Blood and urine Intestinal fistula closure
7 Pneumonia/UTI/Peripheral 
vascular disease
Respiratory/Urinary/Skin Not identified/Candida sp/S. 
aureus
Sputum/Urine/Skin 
secretion
Above-knee amputation
8 Septic arthritis Hip joint Stenotroptomonas maltophilia and 
Staphylococcus coag neg/S. 
agalactiae
Blood and joint fluid Hip drainage
9 Cholecystitis Abdominal/Catheter E. coli/S. aureus Blood/Catheter Cholecystectomy
Mechanical ventilation (n = 9)
Diagnosis Surgery
1 Head trauma (subdural 
haematoma)
Craniotomy
2 Intracerebral haemorrhage Craniotomy
3 Head trauma (subdural 
haematoma)
Craniotomy
Table 3 (Continued)
Detailed description of the surgical patientsCritical Care    Vol 10 No 6    Fialkow et al.
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tosis of peripheral blood neutrophils with the severity of sepsis
and ARDS.
Our study confirms and extends the previous reports of
decreased neutrophil apoptosis in patients with sepsis and
ARDS with or without sepsis [30-33,35,36,38-40]. One study
reported that neutrophil apoptosis was decreased in patients
with sepsis compared with healthy controls [33]. However,
that study combined patients with different degrees of severity
of sepsis into one large group (labelled 'sepsis') that was com-
pared with healthy controls but did not correlate the extent of
neutrophil apoptosis with the severity of sepsis. Other studies
that examined apoptosis of circulating neutrophils from septic
patients assessed only one level of severity of sepsis (for
example, only severe sepsis [30-32] or MODS [35]). Another
study examined the rates of apoptosis of neutrophils in bron-
choalveolar lavage fluid (BALF) of septic patients and demon-
strated decreased apoptosis when all cells (including
neutrophils) from the BALF were analysed ex vivo [36].
In patients with ARDS, our study is in agreement with previous
studies that have demonstrated decreased neutrophil
apoptosis in patients with ARDS, including those with sepsis-
induced ARDS [38-40]. Several studies have documented
that BALF recovered from patients during the early stages of
both septic and non-septic ARDS is able to prolong the life
span of neutrophils incubated ex vivo and that this effect may
be ascribable to elevated levels of cytokines such as granulo-
cyte-colony stimulating factor, granulocyte macrophage-col-
ony stimulating factor (GM-CSF), and interleukin (IL)-2 [38-
40]. Interestingly, Matute-Bello and colleagues [39] reported
that higher GM-CSF levels in BALF correlated with survival in
patients with ARDS. The authors suggested that this effect
may not be related to modulation of neutrophil apoptosis but
rather due to effects on other cells such as alveolar macro-
phages and epithelial cells. Lesur and colleagues [40] also
demonstrated that exposure of normal blood neutrophils to
BALF from patients with ARDS delayed apoptosis in vitro. In
general, these results are in agreement with our observations
and indicate that modulation of apoptosis of neutrophils and
other lung cells is an early phenomenon in the inflammatory
4 Head trauma (subdural 
haematoma)
Craniotomy
5 Head trauma (epidural 
haematoma)
Craniotomy
6 Uterine leyomioma Hysterectomy
7 Abdominal trauma Exploratory laparotomy
8 Head trauma (subdural 
haematoma)
Craniotomy
9 Intracerebral haemorrhage Craniotomy
Controls (n = 11)
Surgery
1 Humeral prostheses
2 Inguinal hernia repair
3 Septoplasty
4 Inguinal hernia repair
5 Arthrodesis (tibia-tarsus)
6 Tibial osteosynthesis
7 Septoplasty
8 Diaphragmatic hernia repair 
and laparoscopic 
fundoplication
9 Iliofemoral bypass
10 Incisional hernia repair
11 Septoplasty
ARDS, acute respiratory distress syndrome; COPD, chronic obstructive respiratory disease; UTI, urinary tract infection.
Table 3 (Continued)
Detailed description of the surgical patientsAvailable online http://ccforum.com/content/10/6/R155
Page 9 of 14
(page number not for citation purposes)
milieu of the lung in sepsis. It is noteworthy that our study is
the first to evaluate apoptosis of peripheral blood neutrophils
specifically from patients with sepsis-induced ARDS.
The mechanisms responsible for the decreased neutrophil
apoptosis in sepsis and ARDS are incompletely understood.
One potential mechanism involves activation of nuclear factor-
κB with a concomitant reduction of the activity of caspases 3
and 9, and maintenance of mitochondrial transmembrane
potential [33]. Other possible mechanisms involve modulation
of Mcl-1 (myeloid cell leukaemia-1) [32], PBEF (pre-B cell col-
ony-enhancing factor) [35], and p38 mitogen-activated protein
kinase (p38 MAPK) [41] signalling pathways.
The current study was stratified (medical/surgical status)
because previous studies have suggested that surgery per se
may influence neutrophil apoptosis [43-46]. Additionally,
because MV has been shown to affect apoptosis in other cell
types [52-57], we included a control group of patients (medi-
cal and surgical) submitted to MV but who had no history of
infection, sepsis, or ARDS.
We observed that the extent of neutrophil apoptosis was sig-
nificantly lower in the surgical controls when compared with
medical controls, an effect that has been reported by others
[43-45]. Indeed, we observed a decrease in neutrophil apop-
tosis in all surgical groups. However, there was no statistical
difference between these groups. Therefore, the correlation
between neutrophil apoptosis and the severity of sepsis
observed in medical patients was not observed in the surgical
groups. There are several factors that might account for the
decreased neutrophil apoptosis in surgical patients, including
effects of anaesthesia and of the localised tissue trauma
related to the surgical procedure with release of cytokines
such as IL-6 [43] and IL-8 [45]. In this regard, a recent study
[58] examined the effects of surgery on Fas-induced neu-
trophil apoptosis and reported that the anti-apoptotic action of
plasma was not affected by the addition of neutralising
antibodies to GM-CSF, IL-6, or IL-8, indicating that these
cytokines are not a dominant factor mediating the anti-apop-
totic effects on Fas-induced apoptosis in surgical patients.
However, the anti-apoptotic effect of plasma was attenuated
by pharmacological inhibitors of either PI3 kinase or
extracellular signal-regulated kinase (ERK), but not by a p38
MAPK inhibitor, implicating PI3 kinase and ERK in the signal-
Table 4
Characteristics of the medical patients
Uncomplicated sepsis 
(n = 8)
Septic shock 
(n = 12)
Sepsis-induced ARDS 
(n = 9)
Mechanical ventilation 
(n = 11)
Controls 
(n = 33)
P value
Age (years, mean ± SEM) 50.8 ± 4.9 56 ± 5.6 43.2 ± 5.8 57.5 ± 4.9 37.1 ± 1.7 <0.008a
Male/Female (percentage) 50.0/50.0 58.3/41.7 44.4/55.6 36.4/63.6 48.5/51.5 0.7b
APACHE II score (percentage) 13.6 ± 2.2 21 ± 2.2 21.5 ± 1.2 - - 0.1
Maximum SOFA score (percentage) 4.7 ± 0.7 9.9 ± 1.0 12 ± 0.8 - - <0.001a
Organ dysfunction (percentage)
05 0 2 5 0 - - -
1 0 16.7 77.8 - - -
2 25 41.7 0 - - -
3 25 16.7 22.2 - - -
Organ failure (percentage)
02 5 0 0 - - -
1 62.5 25 0 - - -
2 12.5 41.7 55.6 - - -
3 0 33.3 33.3 - - -
4 0 0 11.1 - - -
Mortality in 28 days (percentage) 37.5 75 77.8 - - -
Neutrophil apoptosis (mean percentage ± 
SEM)
57 ± 3.2 38 ± 3.7 28 ± 3.3 53 ± 3.0 69 ± 1.1 <0.001a
aP value from the comparisons using analysis-of-variance test; bp value from the comparisons using χ2 test. APACHE II, Acute Physiology and 
Chronic Health Disease Classification System II; ARDS, acute respiratory distress syndrome; SEM, standard error of the mean; SOFA, sequential 
organ failure assessment.Critical Care    Vol 10 No 6    Fialkow et al.
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ling pathway mediating the anti-apoptotic effect of plasma
under the conditions described above. Another study demon-
strated a decrease in apoptosis of exudative neutrophils
obtained from peritoneal fluid from patients with recent gas-
trointestinal surgery [44]. In contrast, a recent report
describes enhanced apoptosis of peripheral blood neutrophils
of patients undergoing elective surgery under general anaes-
thesia [46]. Taken together, alterations in neutrophil function
which occur in the post-operative period may predispose to
untoward outcomes via modulation of the complex inflamma-
tory response to surgery.
Previous studies support the concept that injurious modes of
MV per se may result in release of inflammatory mediators that
lead to inflammatory lung injury [52,53,59,60]. In support of
this notion, we observed that neutrophil apoptosis was dimin-
ished in the group of patients subject to MV but without evi-
dence of infection, sepsis, or ARDS. However, our results also
indicate that MV per se did not account for the low percentage
of neutrophil apoptosis observed in the group of patients with
more complicated sepsis. The effect of MV extends beyond
the lungs to other organs and has been termed 'biotrauma'
[54,55]. Imai and collaborators [52] documented effects of
MV on epithelial cell apoptosis in the lung as well as in the kid-
neys and small intestine, the former accompanied by biochem-
ical evidence of organ dysfunction. A previous study from our
group demonstrated that BALF obtained from ARDS patients
ventilated with injurious MV activated neutrophil oxidant pro-
duction and release of elastase, effects that correlated to the
degree of lung injury and systemic inflammatory response and
to multiple organ failure [61]. Although the effect of BALF on
neutrophil apoptosis was not assessed in this study, we pre-
dict that it would decrease apoptosis. The 'biotrauma' hypoth-
esis is supported by evidence from experimental models,
including humans [59], animals [62], isolated lung [54], and
stressed cell systems [63].
We observed that the mortality rate was higher in medical
patients with ARDS, followed by septic shock, when com-
pared with the uncomplicated sepsis group. To understand
the significance of these mortality rates, we used instruments
such as the total maximum SOFA score to quantify the severity
of illness. From a correlation test evaluating the association
between the mean percentage of neutrophil apoptosis and the
mean SOFA score, two correlations merit further considera-
tion: (a) the correlation between the severity of sepsis and the
percentage of neutrophil apoptosis and (b) the association
among the severity of sepsis, percentage of neutrophil apop-
tosis, and mortality. The correlation analysis suggests an
inverse association between disease severity and the percent-
age of neutrophil apoptosis. Because the mean SOFA score
correlates with mortality [64,65], our findings suggest that
there is an association between the severity of sepsis, the
extent of neutrophil apoptosis, and mortality.
We did not observe an association between neutrophil apop-
tosis and mortality in the current study. One limitation in this
regard is that the sample size was not sufficient to assess such
an association. However, the observed results of the mean
percentage of neutrophil apoptosis, the mean SOFA score,
and the mortality rates suggest that the higher the mortality
rate (and disease severity), the lower the percentage of
neutrophil apoptosis. In future studies with a larger sample
size, it will be important to evaluate whether the percentage of
neutrophil apoptosis is associated with mortality within the dif-
ferent degrees of severity of sepsis.
Figure 1
Apoptosis of neutrophils in a healthy donor and in a patient with sepsis- induced acute respiratory distress syndrome (ARDS) Apoptosis of neutrophils in a healthy donor and in a patient with sepsis-
induced acute respiratory distress syndrome (ARDS). (a) Apoptosis of 
neutrophils in a healthy donor. Wright's Giemsa staining of cytocentri-
fuge smear shows predominance of cells in apoptosis. Inset shows 
morphological detail of an apoptotic cell, with loss of chromatin fine 
granularity (condensation) and karyorrhexis. (b) Apoptosis of neu-
trophils in a patient with sepsis-induced ARDS. Wright's Giemsa stain-
ing of cytocentrifuge smear shows predominance of normal-looking 
cells. Inset shows morphological detail of a normal cell, with fine granu-
larity of chromatin and normal lobulated nucleus. Magnifications ×200 
(insets ×500).Available online http://ccforum.com/content/10/6/R155
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Study limitations
The decrease in the percentage of neutrophil apoptosis may
not be specific for sepsis and ARDS. In fact, it appears that
any event resulting in SIRS (such as sepsis) has the potential
to affect the immune system, including neutrophil survival and
function. However, the patients included in our study, includ-
ing the controls groups, were carefully selected to allow us to
study the specific correlation between neutrophil apoptosis
and sepsis. Our results demonstrate that in medical patients
with sepsis, neutrophil apoptosis is inversely proportional to
the severity of sepsis. The correlations of neutrophil apoptosis
with other causes of SIRS, if any, require further study.
Figure 2
Mean percentage of neutrophil apoptosis in medical patients Mean percentage of neutrophil apoptosis in medical patients. There was a statistically significant difference among the groups (p < 0.001; analysis 
of variance). The differences between individual groups as determined by a post hoc Tukey test are illustrated. ARDS, acute respiratory distress 
syndrome.
Figure 3
Mean percentage of neutrophil apoptosis in surgical patients Mean percentage of neutrophil apoptosis in surgical patients. There were statistically significant differences among the groups (p < 0.001; analysis 
of variance). Post hoc Tukey test results are illustrated. ARDS, acute respiratory distress syndrome.Critical Care    Vol 10 No 6    Fialkow et al.
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The observations in the current study represent an important
first step to a better understanding of the influence of sepsis
on neutrophil apoptosis by defining the clinical associations of
differing degrees of neutrophil apoptosis in this milieu. How
ever, the observational design of the current study did not
allow us to explore the possible mechanism(s) such as the role
of specific receptors and intracellular signalling pathways in
modulation of neutrophil apoptosis during sepsis. Further
studies will be important to address these issues and will pro-
vide important information on the signal transduction path-
ways modulating neutrophil apoptosis during sepsis.
Conclusion
We observed that in medical patients with sepsis, neutrophil
apoptosis is inversely proportional to the severity of this syn-
drome, including ARDS. In surgical patients, the mean per-
centage of neutrophil apoptosis for all sepsis groups was
significantly lower than in the control group, but was not pro-
portional to the severity of sepsis. These observations suggest
that in medical patients, neutrophil apoptosis may be a marker
of the severity of sepsis. We speculate that an influx of long-
lived neutrophils may contribute to enhanced inflammatory
injury to the lungs and other organs. The identification of spe-
cific mechanisms of neutrophil apoptosis in sepsis, including
sepsis-induced ARDS, may lead to new strategies to improve
the survival of those patients and patients with other
inflammatory disorders in which neutrophils have been directly
implicated.
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Table 5
Characteristics of the surgical patients
Uncomplicated sepsis 
(n = 8)
Septic shock 
(n = 11)
Sepsis-induced ARDS 
(n = 9)
Mechanical ventilation 
(n = 9)
Controls 
(n = 11)
P value
Age (years, mean ± SEM) 64.0 ± 3.3 58 ± 7.4 49.5 ± 6.9 51 ± 5 45.9 ± 5.5 0.1
Male/Female (percentage) 75/25 45.5/54.5 55.6/44.4 77.8/22.2 54.5/45.5 0.5a
APACHE II score (percentage) 15.3 ± 1.8 21.1 ± 1.9 21.7 ± 3.9 - - 0.1
Maximum SOFA score (percentage) 6.8 ± 1.1 10 ± 1.3 12.2 ± 0.8 - - <0.001b
Organ dysfunction (percentage)
0 0 9.1 11.1 - - -
1 50 18.2 44.4 - - -
2 37.5 36.4 22.2 - - -
3 12.5 18.2 22.2 - - -
4 0 18.2 0
Organ failure (percentage)
0 12.5 9.1 0 - - -
1 62.5 36.4 11.1 - - -
2 25 36.4 66.7 - - -
3 0 18.2 22.2 - - -
Mortality in 28 days (percentage) 62.5 45.5 66.7 - - -
Neutrophil apoptosis (mean percentage ± 
SEM)
35 ± 3.2 36 ± 5.2 29 ± 2.1 32 ± 3.9 52 ± 3.6 <0.001b
aP value from the comparisons using χ2 test; bp value from the comparisons using analysis-of-variance test. APACHE II, Acute Physiology and 
Chronic Health Disease Classification System II; ARDS, acute respiratory distress syndrome; SEM, standard error of the mean; SOFA, sequential 
organ failure assessment.
Key messages
￿  In medical patients with sepsis, neutrophil apoptosis is 
inversely proportional to the severity of sepsis.
￿  In surgical patients with sepsis, the rate of apoptosis 
was lower than in controls but was not proportional to 
the severity of sepsis.
￿  These observations suggest that in medical patients, 
neutrophil apoptosis may be a marker of the severity of 
sepsis.Available online http://ccforum.com/content/10/6/R155
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